Skip to content
MedsAcross

Medicine

Dextrose 25000 mg/250 mL injection

Dextrose · Intravenous
Available on requestPrescription onlyUS FDAGeneric name

Dextrose 25000 mg/250 mL injection is a generic prescription medicine for intravenous use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Keep from freezing. STORE AT: 20° to 25°C (68° to 77°F), brief exposure up to…

Key facts

Active ingredient (INN)
Dextrose
Brand
Sold under the generic name
Strength
25000 mg/250 mL
Dosage form
Injection
Route
Intravenous
Packs
250 mL, 30 bags of 250 mL, 24 pouches of 250 mL and 2 more
Manufacturers
Baxter HealthcareBecton DickinsonFresenius KabiHealthFirstICU Medical
Origin register
US FDA, United States
Storage
Keep from freezing. STORE AT: 20° to 25°C (68° to 77°F), brief exposure up to 40°C/104°F does not adversely affect the product.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
B05CX01 Dextrose
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
25 January 1971
Identifiers
RxCUI 1795480, 1795477, 1795481 +7DailyMed set ID 4d2d3d3d-d96e-4005-e063-6394a90afd9a, 8e7046f8-841e-465a-af69-af9fb3d6799d, 3bb406a9-f5cb-403a-b1bb-5c4facbea3d5 +2NDC 51662-1680, 17271-721, 0338-0023 +2Application ANDA209448, NDA016694, NDA018080

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
250 mL in 1 bag0338-0023-02Baxter Healthcare25 January 1971
30 bag in 1 case / 250 mL in 1 bag17271-721-05Becton Dickinson5 February 2020
30 bag in 1 case / 250 mL in 1 bag63323-824-74Fresenius Kabi29 March 2019
24 pouch in 1 case / 1 bag in 1 pouch / 250 mL in 1 bag0990-7930-02ICU Medical1 August 2019
250 mL in 1 bag51662-1680-1HealthFirst29 March 2019

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 25 January 1971Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Dextrose

Clinical summary

Dextrose is a prescription medicine indicated as source of water and calories in adult and pediatric patients, and may also be used as a diluent for reconstitution of a powder or liquid drug product. MedsAcross supplies Dextrose for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Dextrose

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Dextrose 25000 mg/250 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.